This hypothesis was tested using the modified Winn assay, whereby the activities of anti-tumor CD8+ cytotoxic T lymphocyte (CTL) were compared with the presence of splenocytes from the treated or non-treated mice [27]. The gene discussed is CD8A; the disease is neoplasm.